This report is a product of the O'Neil Institute for National and Global Health Law at Georgetown Law Center. It provides information on current laws, policies, and court actions in all 50 states related to access to medications for opioid use disorder (MOUD) in correctional facilities in the U.S as of April 2021, including methadone, buprenorphine, and naltrexone. Where available, this survey also includes examples of programs that are county- or facility-specific.